Table 4.
Characteristics of studies included in the meta-analysis
| ||||||||||
Author, yr (Ref) | Country | Study design | PCOS diagnostic criteria | Cancer diagnostic criteria | PCOS group characteristics | Control group characteristics | Outcome of interest | Adjustments | Unadjusted OR (95% CI) | Quality assessment |
Ding et al. , 2018 (11) | Taiwan | Cohort | ICD-9-CM1 Code 256.4 | ICD-9-CM Code 174 and 175 | N = 8155 Age = 27.7 (7.0) BMI = Not reported | N = 32620 Age = 27.5 (7.9) BMI = Not reported | Endometrial, ovarian, and breast cancer | Age, comorbidities | Endometrial cancer OR: 14.685 (4.096, 52.650) ovarian cancer OR:1.60 (0.62, 4.13) breast cancer OR:0.80 (0.47, 1.35) | High |
Harris et al. , 2017 (27) | US | Case-control | Not reported | Not reported | N = 78 Age and BMI not reported for case | N = 4063 Age and BMI not reported for control | Ovarian cancer | Age, study, parity, oral contraceptive use, center, tubal ligation, family history of ovarian cancer | 1.16 (0.74, 1.82) | High |
Kim et al. , 2016 (16) | US | Case-control | Rotterdam criteria | Not reported | N = 67 Age = 53.8 12.2 BMI = 27.4 6.2 | N = 2951 Age = 58.0 12.8 BMI = 26.5 5.7 | Breast cancer | Age, physical activity | 1.30 (0.80, 2.12) | High |
Shen et al. , 2015 (15) | Taiwan | Cohort | NIH4 or ICD-9-CM | ICD-9-CM Code 174 | N = 3566 Age = 27.04 (22.66-32.10) BMI = Not reported | N = 14264 Age = 27.05 (22.72-32.10) BMI = Not reported | Endometrial, ovarian, and breast cancer | Age, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, congestive heart disease, cerebrovascular disease, chronic pulmonary disease, urbanization, and income | Endometrial cancer OR: 10.013 (1.942, 51.629) ovarian cancer OR: 0.89 (0.19, 4.12) breast cancer OR: 1.87 (0.99, 3.53) | High |
Ghasemi et al. , 2012 (29) | Iran | Case-control | Rotterdam | Histologically confirmed | N = 27 Age = 30-51 BMI not reported | N = 305 Age = 30-51 BMI not reported | Breast cancer | None | 0.67 (0.30, 1.48) | Moderate |
Bodmer et al. , 2011 (33) | UK | Case-control | Used diagnosis from GPRD | Based on evidence of cancer-related therapy | N = 28 Age = 61.2 13.1 | N = 10753 Age = 61.2 13.1 | Ovarian cancer | BMI, smoking, prior, use of hormones, history o hysterectomy, endometriosis | 1.55 (0.63, 3.84) | Moderate |
Fearnley et al. , 2010 (28) | Australia | Case-control | Not reported | Histologically confirmed | N = 32 Age 50 yr BMI = not reported | N = 522 Age 50 yr BMI = Not reported | Endometrial cancer | BMI | 3.638 (1.761, 7.515) | High |
Zuchetto et al. , 2009 (34) | Italy | Case-control | Not reported | Histologically confirmed | N = 68 Age = 18-79 BMI not reported | N = 1287 Age = 18-79 BMI not reported | Endometrial cancer | Period of interview, BMI, age at menarche, age at menopause, parity, and oral contraceptive use | 1.171 (0.706, 1.943) | High |
Olsen et al. , 2008 (30) | Australia | Case-control | Not reported | Histologically confirmed | N = 52 Age = 18-79 BMI not reported | N = 3047 Age = 18-79 BMI not reported | Ovarian cancer | Age, education, parity, hormonal contraceptive use, and BMI | 1.15 (0.66, 1.99) | High |
Wild et al. , 2000 (26) | UK | Cohort | Laparoscopic | ICD-7 and ICD-8 | N = 319 Age = 38-98 BMI = 27.1 | N = 1060 Age = 38-98 BMI = 26.2 | Endometrial and breast cancer | BMI | Endometrial cancer OR: 5.923 (1.721, 20.365) breast cancer OR: 1.21 (0.63, 2.31) | High |
Anderson et al. , 1997 (17) | USA | Cohort | Not reported | ICD codes 174.0-174.9 | N = 472 Age = 55-69 BMI = 27.2 0.23 | N = 34363 Age = 55-69 BMI = 27 0.03 | Breast cancer | Age, age at menarche, age at first pregnancy, parity, oral contraceptive use, hormone replacement therapy, BMI, waist to hip ratio, benign breast disease, and family history of breast cancer | 1.18 (0.69, 2.01) | Moderate |
Talamini et al. , 1997 (32) | Italy | Case-control | Not reported | Histologically confirmed | N = 30 Age = 20-74 BMI not reported | N = 5127 Age = 20-74 BMI not reported | Breast cancer | Age at menarche | 0.88 (0.43, 1.81) | Moderate |
Schildkraut et al. , 1996 (13) | USA | Case-control | Not reported | Histologically confirmed | N = 31 Age = 20-54 BMI not reported | N = 4526 Age = 20-54 BMI not reported | Ovarian cancer | Age, parity, and oral contraceptive use | 2.52 (1.08, 5.89) | High |
Escobedo et al. , 1991 (31) | Georgia | Case-control | Not reported | Histologically confirmed | N = 30 Age = 20-54 BMI not reported | N = 3593 Age = 20-54 BMI not reported | Endometrial cancer | Age | 3.757 (1.747, 8.081) | Moderate |
PCOS: Polycystic ovary syndrome, BMI: Body mass index, N: Number, OR: Odds ratio, ICD: International classification of disease, NIH: National institute of health, ICD-9-CM: International classification of diseases, ninth revision, clinical modification, GPRD: General practice research database |